Division of Gastroenterology, Hepatology and Nutrition News

When rumination and gastroparesis collide in patients at Children’s Hospital of Philadelphia, a personalized treatment plan is developed.

Two recent studies show dupilumab improves eosinophilic esophagitis symptoms and pathology for adolescents and young adults.

Researchers from CHOP and Penn are working to perfect 3D models of GI disease and create more personalized treatments for patients.

Regional and local differences in the diagnosis and treatment of celiac disease affects outcomes for youth.

CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.

If your child is complaining about regular belly pain, constipation, nausea or diarrhea, it’s time to talk to your pediatrician.

Research in the lab and at the bedside offer new hope for young patients with biliary atresia, Alagille syndrome and other chronic liver disorders.

Active research at the Fred and Suzanne Biesecker Pediatric Liver Center.

Bench-to-bedside research supports GI innovation at CHOP.

Personalized therapeutic approaches for children with eosinophilic esophagitis are gaining ground at CHOP.